Search all trials

Find therapies in clinical trials near you – page 84

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 968
countries: 28
conditions: 2 103

3 968 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Seasonal allergy

Not recruiting

Registered drug

Study on the Effectiveness and Safety of Phleum Pratense Pollen Extract for Patients with Moderate-to-Severe Grass Pollen Allergy

Registered drug

Germany

Participants:18–64 years
Substances:Loratadine

Contact Research Centre

Malignant melanoma

Not recruiting

Registered drug

Study Comparing Pembrolizumab and Placebo for Patients with Resected High-Risk Stage II Melanoma

Registered drug

Germany

Participants:0–17 years · 18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Deafness neurosensory

Not recruiting

Investigational

Study on ACOU085 to Prevent Hearing Loss in Testicular Cancer Patients Receiving Cisplatin

Investigational

Germany

Participants:18–64 years
Substances:Acou085

Contact Research Centre

Prostate cancer

Not recruiting

Registered drug

Study of Apalutamide and Androgen Deprivation Therapy for Patients with High-Risk Prostate Cancer

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Apalutamide

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drug

Study of Pembrolizumab with Chemotherapy for Patients with Resectable Stage II, IIIA, and IIIB Non-Small Cell Lung Cancer

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Cisplatin

Contact Research Centre

Rheumatoid arthritis

Not recruiting

Registered drug

Study on Nipocalimab and Certolizumab for Patients with Active Rheumatoid Arthritis After Advanced Therapy

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Anhydrous Caffeine

Contact Research Centre

Dermatitis atopic

Not recruiting

InvestigationalNo placebo

Study on the Effectiveness and Safety of Lebrikizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis

InvestigationalNo placebo

Germany

Participants:0–17 years · 18–64 years · 65+ years
Substances:Lebrikizumab

Contact Research Centre

Rheumatoid arthritis

Not recruiting

Registered drug

Study Comparing Upadacitinib and Adalimumab for Adults with Moderate to Severe Rheumatoid Arthritis Not Responding to a Single TNF Inhibitor

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Adalimumab

Contact Research Centre

Retinal artery occlusion

Not recruiting

Registered drug

Study on Alteplase for Vision Recovery in Patients with Acute Central Retinal Artery Occlusion

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Tenecteplase

Contact Research Centre

Oesophageal adenocarcinoma

Not recruiting

Registered drugNo placebo

Study of Sacituzumab Govitecan for Patients with Advanced Esophagogastric Cancer

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Sacituzumab Govitecan

Contact Research Centre

Juvenile spondyloarthritis+2

Not recruiting

Registered drugNo placebo

Study of Ixekizumab and Adalimumab for Children with Juvenile Idiopathic Arthritis, Including Enthesitis-related Arthritis and Juvenile Psoriatic Arthritis

Registered drugNo placebo

Germany

Participants:0–17 years
Substances:Adalimumab

Contact Research Centre

Chronic spontaneous urticaria

Not recruiting

Investigational

Study on the Effects and Safety of Povorcitinib for Adults with Chronic Spontaneous Urticaria

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Povorcitinib

Contact Research Centre

Find therapies in clinical trials near you – page 84

1 128 trials match your criteria

Seasonal allergy

Study on the Effectiveness and Safety of Phleum Pratense Pollen Extract for Patients with Moderate-to-Severe Grass Pollen Allergy

Malignant melanoma

Study Comparing Pembrolizumab and Placebo for Patients with Resected High-Risk Stage II Melanoma

Deafness neurosensory

Study on ACOU085 to Prevent Hearing Loss in Testicular Cancer Patients Receiving Cisplatin

Prostate cancer

Study of Apalutamide and Androgen Deprivation Therapy for Patients with High-Risk Prostate Cancer

Non-small cell lung cancer

Study of Pembrolizumab with Chemotherapy for Patients with Resectable Stage II, IIIA, and IIIB Non-Small Cell Lung Cancer

Rheumatoid arthritis

Study on Nipocalimab and Certolizumab for Patients with Active Rheumatoid Arthritis After Advanced Therapy

Dermatitis atopic

Study on the Effectiveness and Safety of Lebrikizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis

Rheumatoid arthritis

Study Comparing Upadacitinib and Adalimumab for Adults with Moderate to Severe Rheumatoid Arthritis Not Responding to a Single TNF Inhibitor

Retinal artery occlusion

Study on Alteplase for Vision Recovery in Patients with Acute Central Retinal Artery Occlusion

Oesophageal adenocarcinoma

Study of Sacituzumab Govitecan for Patients with Advanced Esophagogastric Cancer

Juvenile spondyloarthritis+2

Study of Ixekizumab and Adalimumab for Children with Juvenile Idiopathic Arthritis, Including Enthesitis-related Arthritis and Juvenile Psoriatic Arthritis

Chronic spontaneous urticaria

Study on the Effects and Safety of Povorcitinib for Adults with Chronic Spontaneous Urticaria

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.